发明名称 ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
摘要 Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
申请公布号 JP6054301(B2) 申请公布日期 2017.01.11
申请号 JP20130546456 申请日期 2011.12.23
申请人 アマゼンティス エスアーAMAZENTIS SA 发明人 リンシュ,クリストファー エル;ブランコ−ボス,ウィリアム;シュネデール,ベルナール;トーマ,シャルレ;サンディ,カルメン;オウェール,ジョアン;アンドル,ペネロプ;フートコーペール,リシャルドゥ;ピリネン,エジャ;ムーシロー,ロレン;ジェヌー,ダヴィ
分类号 A61K31/366;A23L33/10;A23L33/105;A61K36/185;A61P21/00;A61P21/04;A61P25/00;A61P43/00;C12N5/079 主分类号 A61K31/366
代理机构 代理人
主权项
地址